In 2001, late President George H.W. Bush, the forty-first President of the United States, asked Robert A. Ingram, then the CEO of GlaxoWellcome, to convene and chair the CEO Roundtable on Cancer in support of an historic initiative known as C-Change. C-Change (formerly called the National Dialogue on Cancer), is a national forum that brings together our nation's key cancer leaders from government, business, academia and nonprofit sectors, all of whom share a common vision: eliminating cancer.
Specifically, President Bush asked Bob Ingram to form a separate organization, comprised of action-oriented chief executives, and challenged them to "do something more about cancer prevention, diagnosis, and treatment within your own family as well as within your corporate family."
Today, the CEO Roundtable on Cancer, chartered as a 501(c)(3) nonprofit organization in 2005, works to develop and implement initiatives that reduce the risk of cancer, enable early diagnosis, facilitate access to the best available treatments, and hasten the discovery of novel and more effective anti-cancer therapies to help eliminate cancer as a personal disease and public health problem.
The CEO Roundtable on Cancer has responded to President Bush's call to action with the following programs:
- CEO Cancer Gold Standard™ – An employer-led, wellness accreditation program addressing prevention, diagnosis and quality treatment
- Life Sciences Consortium – A collaboration of research organizations addressing grand challenges that cannot be solved by any one entity. One of these is:
- Project Data Sphere, LLC – An independent initiative providing a digital library-laboratory to share, integrate and analyze clinical trial data
- CEO Roundtable on Cancer-China – An invited non-governmental organization (NGO), bringing this employer-led health and wellness model to China